Radar · Traditional Pharmaceuticals in Bengaluru
Best Traditional Pharmaceuticals Companies in Bengaluru, India
The 42 best Traditional Pharmaceuticals companies in Bengaluru, India in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Strides Arcolab.
By Riya SenguptaFinancials
42companies tracked
$291.6Mdisclosed funding
0unicorns
9have raised
FLIAR INTELLIGENCE · TRADITIONAL PHARMACEUTICALS × BENGALURU
Our analysis of 50 Traditional Pharmaceuticals companies
$3.2b in tracked funding; 51% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2016.
50companies analysed
51%cloud-native stacks
2016funding peak (by rounds)
1unicorns
1997median founding year
Ranked: Best Traditional Pharmaceuticals companies in Bengaluru
| # | Company | Disclosed funding | Revenue | Revenue YoY | Employees | Founder | Tech stack | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Biocon Provider of drug research and development services for multiple therapeutic areas | — | $1.9B FY2025 | +5% | 3,681 | Nehal Vora Founder | WordPressMySQLPHP+28 | 1,094 patents Patents concentrated in chemistry & materials | — |
| 2 | Micro Labs Manufacturer of pharmaceutical medications and active pharmaceutical ingredients | — | $769M FY2025 | -2% | 13,101 | Dilip Surana Managing Director & Chairman | Windows ServerBootstrapMicrosoft ASP.NET+11 | 92 patents Formulation and synthesis of ophthalmic and oral pharmaceutical active ingredients | — |
| 3 | Strides Arcolab Manufacturer of IP-led niche finished dosage formulations and soft gelatin capsules 72Market top 20%Fin. health top 22%Moat top 27%Funding top 28% All 9 signals ▾Markettop 20% Fin. healthtop 22% Moattop 27% Fundingtop 28% Growthtop 49% Innovationbottom 43% Patentsbottom 43% Globalbottom 40% Newsbottom 36% Market: 2,157 employees (top 17% of Traditional Pharmaceuticals) · Revenue ~$547M Fin. health: Revenue ~$547M (FY2022) · Net margin 42.4% rank vs industry peers · Fliar Intelligence Index 72/100 | $189M | $547M FY2025 | +18% | 2,157 | — | — | 16 patents Formulating rifaximin oral dosage forms and soft‑gel anti‑inflammatory drug delivery systems. | — |
| 4 | Strides Pharma Science Manufacturer of generic & semi-solids and liquid dosage forms | — | $547M FY2025 | +18% | 643 | — | Tailwind CSSGSAPBackbone.js+7 | — | — |
| 5 | Global Calcium Manufacturer of active pharmaceutical ingredients and mineral actives | — | $70M FY2025 | +2% | 502 | — | PHPYouTubeBootstrap+16 | — | — |
| 6 | Pharmed Provider of therapeutic products | — | $63M FY2025 | +8% | 1,518 | Almutaal Group Ceo | Apple iCloud MailPHPBootstrap+13 | — | — |
| 7 | Symbio Generrics CDMO manufacturer of APIs and Intermediates 22Talent top 28%Moat top 30%Funding top 43%Growth top 50% All 10 signals ▾Talenttop 28% Moattop 30% Fundingtop 43% Growthtop 50% Fin. healthtop 50% Marketbottom 43% Patentsbottom 36% Globalbottom 33% Techbottom 18% Innovationbottom 4% Talent: 3 named leaders on record · 3 C-suite/founder profiles curated Moat: Top 10% by revenue among 1067 tracked Traditional Pharmaceuticals companies · Editorial + unicorn rating 4/10 rank vs industry peers · Fliar Intelligence Index 22/100 | $13M | $51M FY2025 | -11% | 241 241 → 214 (-11%) | Salim Shaikh Co-Founder | PHPW3.CSSBootstrap+10 | 2 patents Biocatalytic production of ursodeoxycholic acid via high‑yield enantioselective enzymes | 1 job opening |
| 8 | RSM Pharma Manufacturer of generics and biosimilar drugs | $25K | $43M FY2025 | +6% | 256 | Vijay Nahar Owner | Adobe FlashNginxGoogle Workspace | — | — |
| 9 | Vacxigen Lifesciences Manufacturer of generic drugs | — | $43M FY2025 | +6% | 256 | Kapil Jain CEO | — | — | — |
| 10 | Bal Pharma Manufacturer of pharmaceutical APIs, formulations, and Ayurvedic products | — | $36M FY2025 | -11% | 825 825 → 1,050 (+27%) | Ramesh Nagubandi Co-Founder | — | — | — |
| 11 | Wintac Manufacturer of injectable and ophthalmic pharmaceutical products | — | $35M FY2025 | +35% | 507 | Jayaprakash Mady Managing Director | — | — | — |
| 12 | BioPlus Developer of novel therapeutics and manufacturer of pharmaceutical products 60Product top 30%Innovation top 34%Growth top 35%Moat top 36% All 11 signals ▾Producttop 30% Innovationtop 34% Growthtop 35% Moattop 36% Talenttop 38% Techtop 43% Fin. healthtop 48% Marketbottom 49% Fundingbottom 48% Globalbottom 37% Newsbottom 22% Product: 4 distinct product lines · Company stage: Series B Innovation: 4 product lines rank vs industry peers · Fliar Intelligence Index 60/100 | $29M | $34M FY2025 | +46% | 291 291 → 530 (+82%) | Sundeep Aurora Chief Executive Officer | WordPressMySQLPHP+18 | — | 1 job opening |
| 13 | Jagdale Manufacturer and processor of food products | — | $23M FY2025 | +3% | 121 | Anju Antony CEO | PHPUbuntuCodeIgniter+8 | — | — |
| 14 | Intra Life Manufacturer of generic drugs | — | $14M FY2025 | +20% | 78 | Rakesh Jain CEO | — | — | — |
| 15 | Anglo-French Drugs Manufacturer of pharmaceutical and nutraceutical products | — | $14M FY2025 | +18% | 222 222 → 366 (+65%) | K Sharma CEO | BootstrapApache HTTP ServerCloudflare+12 | — | — |
| 16 | Zenfold Sustainable Technologies Specialty and fine chemicals company focused on sustainable solutions | — | $8M FY2025 | +116% | 164 164 → 161 (-2%) | Sharath Gunupati Co-Founder | WordPressMySQLPHP+27 | 5 patents Synthesis processes for heterocyclic pharmaceutical intermediates and active drug compounds | — |
| 17 | VPL Chemicals Manufacturer of specialty chemicals, intermediates, and custom synthesized molecules | — | $7M FY2025 | +23% | — | Akash Puranik Co-Owner & Director | PHPApache HTTP ServerModernizr+2 | — | — |
| 18 | Atrimed Developer of herbal based medicine to treat psoriasis, acne and pigmentation | — | $3M FY2025 | +7% | 125 | Shiban Ganju Co-Founder & Chairman | WordPressMySQLPHP+22 | — | — |
| 19 | Sayre Therapeutics Provider of access to innovative therapies for rare and life-threatening diseases | $8M | $3M FY2025 | +7% | 23 23 → 34 (+48%) | Shukrit Chimote Co-Founder & CEO | WordPressMySQLPHP+20 | — | — |
| 20 | Ultralabsindia Ultra Laboratories is a pharmaceutical company that manufactures, distributes, and markets generic medicines. | — | $2M FY2022 | — | 78 | — | YouTubeBootstrapApache HTTP Server+7 | — | — |
| 21 | Bentley & Remington Manufacturer of glucose energy tablets for rapid energy replenishment | — | $2M FY2025 | +6% | 68 | B V Ranka CEO & MD | — | — | — |
| 22 | Steriscience Manufacturer of high-quality medicines | — | $1M FY2025 | — | — | Ankit Gupta Chief Executive Officer | Node.jsSvelteKitSvelte+7 | — | — |
| 23 | Vivifi Life Sciences Manufacturer of pharmaceutical products | — | $994K FY2025 | +22% | 25 | — | TurbopackNode.jsReact+10 | — | — |
| 24 | Trulip Pharmaceuticals Manufacturer of tablets, capsules, syrup, drops, and cream | — | $807K FY2025 | +33% | 187 | — | WordPressPleskMySQL+22 | — | — |
| 25 | Axodin Pharma Manufacturer of generic finished formulations and APIs | — | $558K FY2025 | +7% | — | Rahul Saini CEO | WordPress Block EditorElementorWordPress+32 | — | — |
| 26 | Eyekenz Provider of ophthalmic products including surgical consumables, injectables, and biomedical equipment | — | $403K FY2025 | -16% | 23 | — | BootstrapModernizrDropzone+9 | — | — |
| 27 | STEERLife Developer of drugs and manufacturing equipments | $629K | $203K FY2024 | -70% | 36 | Indu Bhushan CEO & Director | — | 101 patents Pharmaceutical ingredient processing, chemical particle modification, and dosing packaging technologies. | — |
| 28 | Avesthagen Life science company operating at the intersection of food, pharma, and agri-technologies 27Innovation top 16%Patents top 31%Talent top 38%Moat top 42% All 11 signals ▾Innovationtop 16% Patentstop 31% Talenttop 38% Moattop 42% Fundingtop 47% Techtop 50% Globalbottom 42% Growthbottom 25% Marketbottom 24% Newsbottom 18% Fin. healthbottom 15% Innovation: 124 patents (top 16% of patent-holders) Patents: 124 patents matched (strict assignee match) · Latest publication 2018 rank vs industry peers · Fliar Intelligence Index 27/100 | $48M | $189K FY2024 | -52% | 105 | Villoo Morawala-Patell Founder & Managing Director | WordPress Block EditorwpBakeryWordPress+33 | 117 patents Genetically engineered crops enhancing stress tolerance and nitrogen-use efficiency | — |
| 29 | Araya Health Provider of drugs | — | $177K FY2025 | +152% | — | Nikhil Subramanian Co-Founder | — | — | — |
| 30 | Lifezen Manufacturer of eye care, nutritional supplements, and other healthcare needs | $3M | $91K FY2025 | -53% | 9 | Subbarao Prasanna Co-Founder | Cart FunctionalityShopifyAmazon Web Services+24 | — | — |
Top 10 Traditional Pharmaceuticals companies in Bengaluru
#1
Late Stage · Bengaluru, Karnataka · founded 2010 · 241 employees$12.9Mraised▾
Late Stage · Bengaluru, Karnataka · founded 2010 · 241 employees
CDMO manufacturer of APIs and Intermediates
Fliar Intelligence Index™ 22how this company ranks against its industry peers
Talent
top 28%Moat
top 30%Funding
top 43%Growth
top 50%Fin. health
top 50%Market
bottom 43%Talent: 3 named leaders on record · 3 C-suite/founder profiles curated
Moat: Top 10% by revenue among 1067 tracked Traditional Pharmaceuticals companies · Editorial + unicorn rating 4/10 · IP moat: 2 patents
Funding: Raised $12.9M across 2 rounds · 2 rounds over 4 yrs (0.5/yr) · Last round PE (Mar 2022)
Audience (LinkedIn): 12k LinkedIn followers — 7.9% of this cohort's audience · 56 engagements/post (1.8× cohort median)
Hiring (LinkedIn): 4 hiring posts in 12 mo (public) · momentum +4 · hiring: Production – Pellets & Granules team, Assistant Manager
Funding rounds
- Mar 2022PE$12.9M
- Mar 2022Unattributed$68.9K
Founders & team
Investors
Ascent Capital, Aahi Family Trust
Tech stack
AosApache Http ServerBootstrapFont AwesomeIsotopeJquery
#2
Public · Bengaluru, Karnataka · founded 1990 · 2157 employees$189.3Mraised▾
Public · Bengaluru, Karnataka · founded 1990 · 2157 employees
Manufacturer of IP-led niche finished dosage formulations and soft gelatin capsules. This company develops and manufactures these products. It possesses world-class manufacturing facilities and an innovative research and development hub. A robust commercial platform enables global product marketing. The company is known for building and scaling profitable businesses efficiently.
Fliar Intelligence Index™ 72how this company ranks against its industry peers
Market
top 20%Fin. health
top 22%Moat
top 27%Funding
top 28%Growth
top 49%Innovation
bottom 43%Market: 2,157 employees (top 17% of Traditional Pharmaceuticals) · Revenue ~$547M · ~1% of tracked Traditional Pharmaceuticals revenue (1067 cos, FY2025)
Fin. health: Revenue ~$547M (FY2022) · Net margin 42.4% · Revenue +18% YoY
Moat: Top 2% by revenue among 1067 tracked Traditional Pharmaceuticals companies · Editorial + unicorn rating 3/10 · IP moat: 16 patents
Funding rounds
- Sep 2018Post IPO$2.8M
- Jun 2017Conventional Debt$77.5M
- Sep 2014Post IPO$8M
- Sep 2010Post IPO$101M
Investors
KKR, Apax, LifeCell, SV Health Investors
#3
Late Stage · Bengaluru, Karnataka · founded 1998 · 105 employees$48.2Mraised▾
Late Stage · Bengaluru, Karnataka · founded 1998 · 105 employees
Life science company operating at the intersection of food, pharma, and agri-technologies. It focuses on solving major healthcare and environmental challenges through the convergence of food, pharma, and population genetics. It operates pioneering projects such as The Avestagenome Project, which is a large epidemiological study on the Parsi population aimed at understanding longevity and age-related diseases like cancer, cardiovascular disease, diabetes, and neurological disorders. It also develops innovative products and technologies in genomics, bioinformatics, precision medicine, agriculture, and functional foods.
Fliar Intelligence Index™ 27how this company ranks against its industry peers
Innovation
top 16%Patents
top 31%Talent
top 38%Moat
top 42%Funding
top 47%Tech
top 50%Innovation: 124 patents (top 16% of patent-holders)
Patents: 124 patents matched (strict assignee match) · Latest publication 2018 · 6 distinct CPC technology classes
Talent: 2 named leaders on record · 2 C-suite/founder profiles curated
Audience (LinkedIn): 9k LinkedIn followers — 5.8% of this cohort's audience
Activity (LinkedIn): 4 product launches · 2 partnerships (incl. Longevity India, Indian Institute of Science (IISc)) announced in 12 mo
Funding rounds
- Apr 2016Unattributed—
- May 2014Unattributed$132.4K
- Feb 2013Unattributed$34M
- Jun 2012Unattributed$182.6K
Founders & team
Investors
Timesgroup, Fid Funds Mauritius, Bharat Nidhi Limited, Brand Capital, Godrej, Cipla
Tech stack
BootstrapChart.JsCloudflareCloudflare Browser InsightsContact Form 7Core-Js
#4
Series A · Bengaluru, Karnataka · founded 2015 · 23 employees$7.9Mraised▾
Series A · Bengaluru, Karnataka · founded 2015 · 23 employees
Provider of access to innovative therapies for rare and life-threatening diseases. This involves collaborating with global licensors to bring breakthrough therapies to market, tailoring studies to diverse patient populations, and streamlining regulatory pathways. The company also focuses on commercialization and market access, working with doctors to position high-value therapies and ensuring patients receive optimal treatment. A key aspect of the business is expertise in clinical research, regulatory affairs, and sales and marketing within the pharmaceutical industry.
LinkedIn Pulse recent public activity · Jul 2026
Audience: 7k LinkedIn followers — 4.9% of this cohort's audience
Funding rounds
- 2017Venture Debt$1M
- Jan 2017Series A$4M
- Jun 2015Series A$3.9M
Founders & team
Investors
Innoven Capital, Accel, Aarin Capital
Tech stack
Animate.CssApache Http ServerBootstrapChart.JsContact Form 7Core-Js
#5
Series B · Bengaluru, Karnataka · founded 2004 · 291 employees$29.4Mraised▾
Series B · Bengaluru, Karnataka · founded 2004 · 291 employees
Developer of novel therapeutics and manufacturer of pharmaceutical products. This entity focuses on the discovery and development of first-in-class drugs, particularly in the area of pediatric myopia control. It also provides contract manufacturing services and generic pharmaceuticals. The company has a late-stage clinical phase program and a pipeline of pre-clinical programs. Manufacturing capabilities include various dosage forms and active pharmaceutical ingredients (APIs). The firm invests significantly in research and development and clinical development.
Fliar Intelligence Index™ 60how this company ranks against its industry peers
Product
top 30%Innovation
top 34%Growth
top 35%Moat
top 36%Talent
top 38%Tech
top 43%Product: 4 distinct product lines · Company stage: Series B
Innovation: 4 product lines
Growth: Headcount 264 → 291 (+10%) across vintages · Revenue +46% YoY
Audience (LinkedIn): 31k LinkedIn followers — 20.2% of this cohort's audience · 99 engagements/post (3.1× cohort median)
Hiring (LinkedIn): 7 hiring posts in 12 mo (public) · momentum +7 · hiring: Manager / Sr. Manager – Medical Affairs (Clinical Development), Scientist/Sr. Scientist
Funding rounds
- Jun 2008Series B$29.4M
Founders & team
Investors
AIF Capital, Sushmatrust, Neha Trust
Tech stack
Animate.CssBootstrapCdnjsCloudflareFont AwesomeGoogle Font Api
#6
Early Stage · Bengaluru, Karnataka · founded 1993 · 36 employees$629Kraised▾
Early Stage · Bengaluru, Karnataka · founded 1993 · 36 employees
Developer of drugs and manufacturing equipments
Funding rounds
- Dec 2019Unattributed$629K
- Mar 2017Unattributed—
Founders & team
Investors
Vistra ITCL, Ledger, Prasthavana
Tech stack
Google MapsYoutubeAnimate.CssRequirejsApache Http ServerJquery
#7
Series A · Bengaluru, Karnataka · founded 2014 · 9 employees$3.2Mraised▾
Series A · Bengaluru, Karnataka · founded 2014 · 9 employees
LifeZen is an OTC subsidiary of Bal Pharma operating in eye care and nutraceutical segments. Its main product is EyeSpa, which is an OTC eye care product. It is indicated for dry eyes caused by lifestyle disorders and by other conditions such as rheumatoid arthritis, diabetes, etc. It has nutraceutical products such as calcium supplements (Tuskca) and probiotics (WonderPro).
Funding rounds
- Mar 2015Series A$3.2M
Founders & team
Investors
Brand Capital
Tech stack
Amazon S3Amazon Web ServicesAmerican ExpressApple PayCart FunctionalityCloudflare
#8
Public · Bengaluru, Karnataka · founded 1978 · 3681 employees—raised▾
Public · Bengaluru, Karnataka · founded 1978 · 3681 employees
Provider of drug research and development services for multiple therapeutic areas. It also provides research services on gene therapy, API development, generic formulations, quality control, and scientific services.
Founders & team
Investors
True North, Kotak Mahindra Bank, Serum Life Sciences, ADQ, Tata Capital Growth Fund, Goldman Sachs
Tech stack
AddtoanyAddtoany Share ButtonsAnimate.CssApache Http ServerBootstrapCloudflare
#9
Seed · Bengaluru, Karnataka · founded 1989 · 256 employees$24.7Kraised▾
Seed · Bengaluru, Karnataka · founded 1989 · 256 employees
Manufacturer of generics and biosimilar drugs
Funding rounds
- Mar 2008Seed$24.7K
Founders & team
Investors
Entero Healthcare
Tech stack
Adobe FlashGoogle WorkspaceNginx
#10
Seed · Bengaluru, Karnataka · founded 2019—raised▾
Seed · Bengaluru, Karnataka · founded 2019
Manufacturer of immunity based health products
Funding rounds
- Oct 2019Angel—
Founders & team
Investors
SR Innovation Exchange
Funding & investor landscape
$291.6Mtotal disclosed funding
8companies funded
28disclosed rounds
0rounds last 90 days
Most active investors
Aahi Family Trust1 rounds
Accel1 rounds
Arun Kumar's Family Office1 rounds
Notable founders
Salim Shaikh
Co-Founder · Symbio Generrics
Abhijit Kale
Co-Founder · Symbio Generrics
Villoo Morawala-Patell
Founder & Managing Director · Avesthagen
Narayanaswamy Kollur
CEO · Avesthagen
Shukrit Chimote
Co-Founder & CEO · Sayre Therapeutics
Sundeep Aurora
Chief Executive Officer · BioPlus
Sunjeev Aurora
Director · BioPlus
Indu Bhushan
CEO & Director · STEERLife
Subbarao Prasanna
Co-Founder · Lifezen
Nehal Vora
Founder · Biocon
Vijay Nahar
Owner · RSM Pharma
Vikash Kumar
Founder & CEO · Hilt Brands
Prism market signals · India · country-scoped Prism corpus, 431,747 docs
Market landscape — 10 sub-themes by coverage
Share of Traditional Pharmaceuticals coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
RESEARCH IN BENGALURU · Health & Bio
How research on Drug Discovery in Bengaluru is moving
A read on the academic research around Drug Discovery in Bengaluru — which themes are gaining ground, the institutions and researchers driving them, and how the tone is shifting. Based on 96 papers.
96 papers · stance +0.62 · 44% breakthrough · 7% concern
top institutions
- Indian Institute of Science Bangalore31
- Indian Institute of Science Education and Research, Bhopal15
- National Centre for Biological Sciences10
- Bangalore University8
- Indian Institute of Science Education and Research Pune7
leading researchers
Durga Prasad Hari · Malay Kumar Rana · Parth Sarthi Sen Gupta · Saroj Kumar Panda · Vikas Tiwari · Abdur Rouf Samim Mondal
prism intelligence · tone & topics
97% positive · 1% critical tone
PharmaceuticalsHealthBiotechnologyHealthcareMedical ResearchMedicine
▲
Breakthroughs39 · 41%
▲ 0%→41% share
1 median citations97% since 2021mostly methods-led
Breakthroughs are rising (0%→41% of field), led by Chemical space.
rising sub-themes (early→recent)
- Chemical space5
- Computational biology5
- Small molecule5
- Catalysis4
- In silico4
Newly emergingChemical space 0→5 · Computational biology 0→5 · Small molecule 0→5
Landmark XTMS: pathway design in an eXTended metabolic space · 110 cites
◆
Advancements44 · 46%
▲ 0%→46% share
1 median citations95% since 2021mostly empirical
Advancements are rising (0%→46% of field), led by Computational biology.
rising sub-themes (early→recent)
- Computational biology14
- In silico9
- Virtual screening5
- Docking (animal)5
- Pharmacophore4
Newly emergingComputational biology 0→14 · In silico 0→9 · Virtual screening 0→5
Landmark Antibiotic Resistance: Current Perspectives · 140 cites
▼
Concerns6 · 6%
▲ 0%→5% share
4 median citations83% since 2021mostly reviews
Concerns are rising (0%→5% of field), led by Subclass.
rising sub-themes (early→recent)
- Subclass1
- Drug resistance1
- Antibiotic resistance1
- Antibiotics1
- Population1
Landmark Human Pluripotent Stem Cell Culture: Current Status, Challenges, and Advancement · 118 cites
PATENT MOMENTUM · Bengaluru
Who's building drug discovery IP in Bengaluru
1438 patents64 companiespeak 107/yr
filing momentum (YoY)
top patenters
- Biocon662Bengaluru
- Connexios Life Sciences100Bengaluru
- sami-sabinsa group98Bangalore
- Micro Labs89Bengaluru
- Lyrus Life Sciences36Bengaluru
- Naresh Kumar33Bengaluru
- Aten Porus Lifesciences33Bengaluru
- BioSouk Life Sciences32Bengaluru
Common questions
How many Traditional Pharmaceuticals companies are there in Bengaluru, India?
Radar tracks 42 indexable Traditional Pharmaceuticals companies headquartered in Bengaluru, India that meet our profile-completeness bar.
What is the total funding raised by Traditional Pharmaceuticals companies in Bengaluru, India?
The Traditional Pharmaceuticals companies in Bengaluru, India on this list have raised a combined $291.6M in disclosed equity funding across 8 funded companies.
Which is the highest-funded Traditional Pharmaceuticals company in Bengaluru, India?
Strides Arcolab is the highest-funded Traditional Pharmaceuticals company in Bengaluru, India, with $189.3M in disclosed equity funding.
How many Traditional Pharmaceuticals companies in Bengaluru, India are funded?
8 of the 42 Traditional Pharmaceuticals companies in Bengaluru, India on this list have disclosed at least one equity funding round.
How many Traditional Pharmaceuticals unicorns are there in Bengaluru, India?
None of the Traditional Pharmaceuticals companies in Bengaluru, India on this list currently has a disclosed valuation of $1B or more.
Who are the top investors in Bengaluru, India Traditional Pharmaceuticals companies?
The most active investors in Bengaluru, India Traditional Pharmaceuticals companies on this list include BIRAC, Brand Capital, ADQ, AIF Capital, Aahi Family Trust.
Riya SenguptaFinancials
Riya reads income statements for fun. She covers the real money in a sector — revenue, growth, who actually earns — and never met a vague claim she didn't want a number for.